Fennec Pharmaceuticals Inc.
FENC
$6.68
$0.142.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -141.16% | 88.89% | 43.24% | -109.08% | 25.99% |
| Total Depreciation and Amortization | 90.05% | 4.00% | -3.85% | -96.40% | -- |
| Total Amortization of Deferred Charges | -71.58% | -42.86% | -43.48% | -35.00% | 35.71% |
| Total Other Non-Cash Items | 600.62% | -91.24% | 98.35% | -45.13% | 546.59% |
| Change in Net Operating Assets | -17,596.15% | 155.92% | 23.81% | -117.05% | 102.15% |
| Cash from Operations | -304.48% | 167.68% | 56.05% | -111.06% | 69.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -49.82% | -- | -- | -- | -- |
| Issuance of Common Stock | 5,201.63% | -- | -- | -40.83% | 6.69% |
| Repurchase of Common Stock | -188.89% | 90.53% | -215.56% | 36.84% | 47.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 270.35% | 431.25% | -210.51% | 131.71% | -313.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 208.44% | 218.58% | 51.17% | -110.44% | -1,673.10% |